The relation between dietary fat, blood lipids, plasma factor VII coagulant activity (FVIIc) and risk of coronary heart disease (CHD) according to the R353Q polymorphism in the factor VII gene was assessed. 
Introduction
Fat intake, especially saturated fatty acid (SFA) intake, is an important determinant of coronary heart disease (CHD) risk, either through its role in raising total low-density lipoprotein (LDL) cholesterol or through a possible role in the coagulation system. Initial interest in the effects of dietary fat on factor VII coagulant activity (FVIIc) followed from reports showing a positive association between non-fasting FVIIc and CHD risk (Meade et al., 1986) . Since then, several studies, but not all, have shown associations between both non-fasting and fasting FVIIc and total fat intake (Miller et al., 1989; Larsen et al., 1997; Mennen et al., 1997) with smaller (Sanders et al., 1999; Junker et al., 2001; AllmanFarinelli et al., 2005) or negligible (Larsen et al., 1997; Roche and Gibney, 1997; Lindman et al., 2003) effects of fatty acid composition. The exact biochemical basis of the effects of dietary fat on FVIIc remains to be elucidated, but some of these conflicting results may have been due to variants in genes controlling FVII metabolism. A common single nucleotide polymorphism in exon 8 of the FVII gene, comprising of a G to A substitution in the second position of the codon for amino acid 353, leads to the substitution of arginine (Arg, R) to glutamine (Glu, Q) in the protein product, which is associated with a reduction in FVIIc of around 20% (Green et al., 1991) . How this substitution affects the level of FVIIc is not fully understood, but it has been postulated that the change from this is likely to alter the conformation of the FVII Gln353 protein (Humphries et al., 1992) and diminish secretion from the liver (Hunault et al., 1997) . Few studies have information on diet, FVIIc, blood lipids and genotype that are sufficiently large to examine a possible interaction between fat intake and blood lipids according to genotype, for example, in RR homozygotes versus Q allele carriers of the R353Q polymorphism. We have therefore tested associations in the Norfolk arm of the European Prospective Investigation of Cancer and Nutrition (EPIC) study (Day et al., 1999) where plasma FVIIc levels and confounding factors, such as serum triacylglycerol levels (Simpson et al., 1983; Miller et al., 1991) , cholesterol (Mitropoulos et al., 1987) and smoking (Donati et al., 2000) , were measured. We also assessed whether the R353Q genotype was associated with risk of CHD development as previously found in some populations (Meade et al., 1986; Iacoviello et al., 1998; Girelli et al., 2000) , but not in others (Lane et al., 1996; Feng et al., 2000; Lindman et al., 2004) , both by a nested case-control and a case-cohort analysis.
Subjects and methods

Subjects
The European Prospective Investigation of Cancer (EPIC) Norfolk (Day et al., 1999 ) is a prospective study of 25 663 men and women between the age of 40 and 79, recruited from 35 medical practices in Norfolk (UK) between 1993 and 1997. The study was approved by the Norfolk and Norwich Hospital Ethics Committee and all participants gave signed informed consent.
All participants completed two health examinations; the first health check was between 1993 and 1997 and the second was between 1998 and 2000. Participants were flagged and followed up for CHD and other conditions via death certificates and hospital linkage (Day et al., 1999) . All hospital admissions were coded using International Classification of Disease, 10th Revision (ICD-10) codes I20-I25. Death certificates were coded using a combination of ICD-9 codes 410-414 and ICD-10. Incident CHD cases were selected as those who either had CHD mentioned anywhere on their death certificate or CHD on their hospital discharge codes during follow-up. Prevalent cases of CHD reported on recruitment were excluded from the analysis.
Study design
The factor VII R353Q genotype-specific effects of blood lipids and fat intake on plasma FVIIc were investigated crosssectionally in 7433 individuals. The effect of the factor VII R353Q polymorphism upon incident CHD was investigated in 15 073 genotyped individuals, disease free at the baseline assessment, after a mean follow-up of 9.5 years.
In addition, the association between the R353Q polymorphism and CHD risk was investigated in a nested casecontrol study of 985 CHD cases and 2009 matched controls after a mean follow-up of 8.6 years. Incident CHD cases were matched with two controls by gender, date of birth ±3 years and date of health check ± 3 months. When controls could not be found, the criterion for the date of health check was widened to ±6 months.
Data collection
A food frequency questionnaire (FFQ) consisting of 131 items (Bingham et al., 2001) was completed prior to the first health check. An in-house computer program called the Compositional Analyses from Frequency Estimates (CAFE), with an associated database, was developed for data entry, analysis and conversion to nutrient intakes using food table databases for the UK published by the Royal Society of Chemistry (Welch et al., 2005) . At the conclusion of the first health check, participants completed a 7-day food diary (Bingham et al., 2001) . Food diary data were entered using DINER (Data Into Nutrients for Epidemiological Research) ; at the time of analysis, data were available for 3323 of the 7433 individuals who had plasma FVIIc measured.
During the health checks, height, weight, anthropometry and systolic blood pressure (SBP) were measured and blood samples were obtained. Participants also completed a detailed health and lifestyle questionnaire (Day et al., 1999) . Exercise was measured by the means of a simple physical activity index, ranging on a scale from 1, lowest activity group, to 4, highest activity group. The use of the simple physical activity index was previously validated (Wareham et al., 2003) .
Non-fasting blood collected in plain and citrated monovettes at the first health check was used for serum lipid and plasma FVIIc analyses, respectively; DNA was extracted from non-fasting whole blood collected in EDTA monovettes at the second health check.
Biochemical analyses
Total cholesterol, high-density lipoprotein (HDL) cholesterol and triacylglycerol were measured in serum on an RA-1000 (Bayer Diagnostic, Basingstoke, UK). LDL cholesterol was calculated using the Friedewald formula (Friedewald et al., 1972) ; when serum triacylglycerol exceeded 4 mmol/l, LDL cholesterol was not calculated.
Plasma FVIIc was measured using the MDA PT-based assay (Organon Teknika, Durham, NC, USA). This is a one-stage assay based on the prothrombin time test using Simplastin Excel S (Organon Teknika). Factor VII-deficient plasma is used as the substrate and the clotting time with the individual plasma is expressed as a percentage of the clotting time of normal pooled plasma. Owing to cost limitations, only half of the samples were analysed for plasma FVIIc. . The samples were then prepared as described elsewhere (Ronaghi et al., 1996) , with the sequencing primer 5 0 -CAGGTAC-CACGTGCC-3 0 . Samples were loaded into the machine and scored using the PSQ 96MA 2.1 Operating Software (Biotage). The pyrosequencing assay was validated against an established restriction fragment length polymorphism (Green et al., 1991) .
Statistical analysis Descriptive analysis. Baseline characteristics are presented as means with s.d. or percentages. The w 2 goodness-of-fit was used to verify the agreement of the observed genotype frequencies with those expected (Hardy-Weinberg equilibrium). Differences between genotypes and between genders in baseline characteristics were examined using analysis of variance or the w 2 test.
Cross-sectional analysis. The impact of serum lipids and dietary intake on plasma FVIIc levels was investigated by hierarchical multiple linear regression, separated by gender (due to a significant effect of gender). Confounding variables were identified by correlation analysis. The regression analyses were adjusted for age, body mass index, smoking status, physical activity index, energy intake, alcohol intake and carbohydrate intake. Owing to high correlations between the serum lipids and between the dietary constituents, the effects of these variables were evaluated in separate regression models. Additional regression models were used separately for the different genotype groups. To allow the magnitude of the regression coefficients to be compared, the results are presented as the standardized b-coefficient with standard error (s.e.) or 95% confidence interval (95% CI) and two-tailed test of significance (P-value (Table 2) was not different between genotypes. Fat intake (g/day) was higher in male than female RR homozygotes and RQ heterozygotes (Table 2) . Fat intake as a percentage of energy intake (en%) was also higher in males than females (total fat 33.7 en% males, 32.8 en% females, Po0.0001; SFA 13.0 en% males, 12.5 en% females, Po0.0001; monounsaturated fatty acids (MUFA) 12.0 en% males, 11.4 en% females, Po0.0001; polyunsaturated fatty acids (PUFA) 6.3 en% males, 6.4 en% females, P ¼ 0.04).
Factor VII and dietary intake
Numbers of QQ homozygotes were low and so they were combined with the RQ heterozygotes to test the influence of the Q allele in comparison with the RR genotype.
Cross-sectional analysis R353Q polymorphism, plasma FVIIc and blood lipids. Table 3 shows that in both genders, FVIIc was positively correlated with total and HDL cholesterol and triacylglycerol, and this association remained when RR homozygotes and Q allele carriers were considered separately for total cholesterol and for triacylglycerol. There were no statistically significant interactions between genotype and the plasma FVIIc response to total (Z ¼ 1.34; P40.05) and HDL (Z ¼ À0.45; P40.05) cholesterol and triacylglycerol (Z ¼ 0.67; P40.05) in females. Results for total cholesterol were similar in males (Z ¼ 0.89; P40.05). However, there was a significant interaction between genotype and the FVIIc response to triacylglycerol (Z ¼ À2.24; Po0.05); the association of FVIIc with triacylglycerol was stronger in male Q allele carriers than in male RR homozygotes (Table 3; Figure 1 ). R353Q polymorphism, plasma FVIIc and fat intake. Plasma FVIIc was significantly and positively associated with total fat and MUFA intake in females but there were no associations with dietary SFA, PUFA or fibre (Table 4 ). The association with total fat intake was confined to the female RR homozygotes (Po0.01), with a similar trend for MUFA (Table 4) . Results were similar when expressed as % of energy intake, with no evidence of interaction (data not shown). Seven-day food diaries were available for a subgroup of 1660 females and 1663 males. Compared with the FFQ, absolute amounts of total fat, SFA, MUFA and PUFA intakes from 7-day food diaries were significantly lower (female 64.7, 21.7, 18.6 and 10.3 g/day; male 82.1, 27.6, 24.2 and 13.2 g/ day, respectively) (Po0.0001; Table 2 ). However, values from the FFQ and food diary were highly correlated (Po0.0001), and coefficients from the food diaries were in the same direction as the FFQ; for females, the standardized coefficients with standard errors (b ± s.e.) were 0.30 ± 0.11 for total fat, À0.05±0.05 for SFA, 0.09±0.05 for MUFA, 0.07±0.03 for PUFA and À0.05±0.03 for fibre; for males, the values were 0.09 ± 0.11 for total fat, 0.03 ± 0.04 for SFA, 0.06 ± 0.05 for MUFA, 0.05±0.03 for PUFA and À0.03±0.03 for fibre. The proportion of genotypes was the same in the food diary and FFQ groups (diary RR 80.2%, RQ 18.6%, QQ 1.3%), but owing to loss of statistical power from the smaller numbers available, analysis by genotype was not possible.
R353Q polymorphism and risk of CHD. In the nested casecontrol study, there was no significant effect on risk of CHD among the Q allele carriers compared with the RR homozygotes in both females (OR 0.76, 95% CI 0.53-1.10, P ¼ 0.14) and males (OR 0.88, 95% CI 0.69-1.13, P ¼ 0.32). Analysis of both genders together yielded similar results when adjusted for age and gender (OR 0.91, 95% CI 0.75-1.11, P ¼ 0.37) and for the fully adjusted model (OR 0.89, 95% CI 0.77-1.02, P ¼ 0.10).
In the case-cohort analysis, the percentage of CHD cases in males (male RR 12.6%, RQ 12.0%, QQ 15.4%) was significantly higher for all genotypes (Po0.0001) compared with females (female RR 6.4%, RQ 4.6%, QQ 5.2%). There was a statistically significant effect of genotype on the number of CHD cases in females, with significantly lower percentages in Q allele carriers (P ¼ 0.03). Factor VII and dietary intake R Bowman et al
Discussion
In this large cross-sectional study, triacylglycerol levels were positively associated with FVIIc levels in both females and males, as shown in previous studies (Miller et al., 1991; Sanders et al., 2000) . Moreover, we show here that there was a significant interaction with the R353Q genotype in males; an increase in triacylglycerol levels of 1 s. (Figure 1 ). These increases were three to five times greater in magnitude than previous results (Lane et al., 1996; Feng et al., 2000) . Interestingly, the greater effect was seen in carriers of the Q allele, which is in contrast with the hypothesized protection of the Q allele against CHD risk and deserves further research. Genetic influences in common to FVII and triacylglycerol accounted for 7% of the variance in FVII in a sample of Swedish twins (Hong et al., 1999) , which may explain the genotype-dependent association. We measured serum lipids in the non-fasting state. However, blood sampling would have had no major effect on our analysis as indicated in a meta-analysis that showed no differences in triacylglycerol-associated CHD risk between non-fasting and fasting participants (Sarwar et al., 2007) . Mean values were within normal reference values expected in a population reporting to be healthy at the time of the blood collection.
The RR homozygotes have an increased risk of CHD in some (Iacoviello et al., 1998; Girelli et al., 2000) , but not in other (Lane et al., 1996; Feng et al., 2000; Lindman et al., 2004) , studies of European and American populations with similar genotype frequencies of 71-83% RR homozygotes, 16-26% RQ heterozygotes and 1-4% QQ homozygotes. We found a difference in the distribution of CHD cases in females, but not in males, with lower percentages in female Q allele carriers compared with RR homozygotes. However, there was no significant association between the R353Q polymorphism and CHD risk in the nested case-control study, even when we controlled for smoking, which is associated with other coagulation and CHD risk factors and appears to increase the risk of myocardial infarction in carriers of the protective Q allele (Iacoviello et al., 1999) .
Few large-scale studies have investigated dietary CHD risk factors for their relationship with FVIIc. We found that total fat intake was positively and significantly related to FVIIc in females overall, with no associations in males. MUFA intake was positively associated with FVIIc in females. For SFA, the association in females (P ¼ 0.02) did not reach the acceptable level of significance set to account for multiple testing (a ¼ 0.01). Our results support the positive association between non-fasting FVIIc and total fat intake, which was found previously in a smaller group of 1730 females but not in males (Mennen et al., 1997) , although this was not replicated in a subgroup analysis of 1158 subjects from the same cohort (Mennen et al., 1997 (Mennen et al., , 1998 . In females homozygous for the R allele, an increase in total fat intake of 27.4 g/day (1 s.d.) was significantly associated with an increase in FVIIc of 8.0% (0.24 s.d.). Otherwise, we did not find any associations between diet and FVIIc in either of the genotypes in males. There is no explanation suggested elsewhere for any possible gender-specific effects. Fibre intake is inversely associated with CHD risk (Pereira et al., 2004) , possibly due to lowering of LDL cholesterol or blood pressure, improving insulin sensitivity or a combination of these factors. Reduced LDL cholesterol may in turn result in a lower FVIIc. However, we did not find any significant association between FVIIc and fibre intake. The use of the FFQ may attenuate associations through measurement error (Wu et al., 2007) . However, the available cross-sectional results from 7-day food diaries in our subgroup were in the same direction as the FFQ results. In addition, we have a relatively large population covering a wide range of macronutrient intakes. Nevertheless, our results may only apply to populations with similar characteristics.
In brief, results from this large population study indicate that R353Q genotype only marginally affects modulation of FVIIc by dietary fat. Factor VII and dietary intake R Bowman et al
